When is hemodialysis indicated for hepatic encephalopathy and what are the recommended protocols for its use?

Hemodialysis is NOT a standard treatment for hepatic encephalopathy and should only be considered in the highly specific scenario of concurrent end-stage renal disease requiring renal replacement therapy.

Primary Management of Hepatic Encephalopathy

The cornerstone of hepatic encephalopathy (HE) management does not involve hemodialysis. Instead, treatment follows a four-pronged approach 1:

1. Initiation of care for altered consciousness (airway protection, ICU monitoring for grades III-IV)
2. Identify and treat alternative causes of altered mental status
3. Identify and correct precipitating factors (nearly 90% of patients respond to this alone 1)
4. Commence empirical HE treatment with lactulose

First-Line Pharmacologic Treatment

Lactulose (or lactitol) is the recommended first-line treatment for overt HE 2:

• Start with 25 mL every 1-2 hours until producing 2-3 soft bowel movements daily
• Titrate to maintain 2-3 bowel movements per day
• Associated with reduced mortality and resolution of HE 2
• Critical pitfall: Overuse causes aspiration risk, dehydration, hypernatremia, and can paradoxically worsen HE 1

Second-Line Treatment

Add rifaximin 550 mg twice daily when lactulose alone fails or after recurrent episodes 2:

• Reduces HE recurrence by 58% when added to lactulose
• Improves quality of life and reduces hospitalizations
• Safe for long-term use (>24 months) 2

When Hemodialysis Becomes Relevant

Hepatorenal Syndrome Context

Hemodialysis is mentioned in guidelines only in the context of hepatorenal syndrome, not as treatment for HE itself 3:

• Used to control azotemia and electrolyte balance before liver transplantation
• Hypotension during dialysis is a common problem
• Without transplantation, survival is dismal
• Continuous venovenous hemofiltration causes less hypotension but requires intensive nursing

Special Population: End-Stage Renal Disease

Hemodialysis or hemodiafiltration may benefit HE only when patients have concurrent ESKD requiring renal replacement therapy 4, 5:

• Online hemodiafiltration (HDF) may improve amino acid profiles (increases Fischer's ratio, decreases tryptophan)
• Case reports show HDF superior to standard hemodialysis for HE in ESKD patients 4
• In acute liver failure with ESKD, HDF maintained consciousness in 94% of patients 5

Albumin Dialysis Systems

Albumin dialysis (e.g., Prometheus® system) ameliorates HE but has uncertain prognostic impact 6, 7:

• Can be considered in patients with liver failure and overt HE
• Requires further study to establish mortality benefit
• Not a standard recommendation in major guidelines

Critical Clinical Algorithm

For any patient with HE:

1. Exclude other causes of encephalopathy (normal ammonia questions the diagnosis 1, 6)
2. Identify precipitating factors: infection, GI bleeding, constipation, medications, electrolyte abnormalities, dehydration
3. Start lactulose immediately while correcting precipitants
4. If renal failure coexists: Standard hemodialysis for renal indications only; consider HDF if available 4
5. If HE persists or recurs: Add rifaximin to lactulose 2
6. If refractory: Evaluate for liver transplantation 1, 6

Key Caveats

• Hemodialysis does NOT directly treat HE in patients with normal renal function
• The historical use of hemodialysis for HE in fulminant hepatic failure 8 predates modern medical management and is not supported by current guidelines
• Diuretics should be discontinued in patients with persistent overt HE 9
• Liver transplantation remains the definitive treatment for recurrent intractable HE 1